Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

VRPX Virpax Pharmaceuticals Inc

0,72

-0,0805 (-10,06%)

08 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Virpax Pharmaceuticals Charts.

Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Virpax Pharmaceuticals Charts.

News Virpax Pharmaceuticals Inc

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
Mittwoch 29 Mai 2024 (1 Woche vor) • Business Wire

Form 8-K - Current report
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Donnerstag 16 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Virpax Announces Pricing of $2.25 Million Public Offering
Mittwoch 15 Mai 2024 (3 Wochen vor) • Business Wire

Form EFFECT - Notice of Effectiveness
Mittwoch 15 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments
Montag 13 Mai 2024 (4 Wochen vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
Dienstag 30 April 2024 (1 Monat vor) • Business Wire

Virpax Pharmaceuticals Reports 2023 Year-End Results
Dienstag 26 März 2024 (2 Monate vor) • Business Wire

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
Dienstag 27 Februar 2024 (3 Monate vor) • Business Wire

Weitere Virpax Pharmaceuticals Inc News-Artikel

Euro vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen